Harada, M.; Nakajima, T.; Yamada, Y.; Aomura, D.; Yamaguchi, A.; Sonoda, K.; Tanaka, N.; Hashimoto, K.; Kamijo, Y.
Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. J. Clin. Med. 2022, 11, 762.
https://doi.org/10.3390/jcm11030762
AMA Style
Harada M, Nakajima T, Yamada Y, Aomura D, Yamaguchi A, Sonoda K, Tanaka N, Hashimoto K, Kamijo Y.
Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. Journal of Clinical Medicine. 2022; 11(3):762.
https://doi.org/10.3390/jcm11030762
Chicago/Turabian Style
Harada, Makoto, Takero Nakajima, Yosuke Yamada, Daiki Aomura, Akinori Yamaguchi, Kosuke Sonoda, Naoki Tanaka, Koji Hashimoto, and Yuji Kamijo.
2022. "Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study" Journal of Clinical Medicine 11, no. 3: 762.
https://doi.org/10.3390/jcm11030762
APA Style
Harada, M., Nakajima, T., Yamada, Y., Aomura, D., Yamaguchi, A., Sonoda, K., Tanaka, N., Hashimoto, K., & Kamijo, Y.
(2022). Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. Journal of Clinical Medicine, 11(3), 762.
https://doi.org/10.3390/jcm11030762
